Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field.
May 27, 2025
Join us in San Francisco, CA, USA, July 12-15, 2025, for ENDO 2025. With over 7,000 attendees, nearly 2,500 abstracts and over 200 other sessions, ENDO is the leading global meeting on endocrinology research and clinical care. ENDO’s comprehensive program provides attendees the opportunity to learn about the latest developments in hormone science and medicine from renowned investigators, expert clinicians, and educators from all over the world.
June 13, 2025
Registration is open for our leading online training program for fellows, residents, and physicians preparing for the board certification exam. Maximize your score in Endocrinology, Diabetes, & Metabolism with a study guide and expert insights. Registration includes a printed book, interactive practice exams, and topical Q&A sessions. Register now
June 04, 2025
Navigate the complexities of endocrine care for children and adolescents with the Pediatric Endocrine Self-Assessment Program (ESAP)™ 2025–2026. Enhance patient care with 100 new case-based questions covering growth, diabetes, reproduction, and more. Available in print, eBook, and online, with interactive modes to build knowledge and confidence. Order now.
June 13, 2025
Discover the latest advances in hormone health treatments at CEU 2025 on October 23- 25. Our comprehensive, case-based agenda will help you gain new skills that you can immediately apply in your practice. Join the best in clinical sessions covering nine topical categories and earn up to 27 AMA PRA Category 1 Credits™. Eligible physicians may also claim up to 9 ABIM MOC Points. Register today
June 20, 2025
Read about two recent court decisions affecting endocrine health and our recent policy communication efforts.
Need more info?
Learn more about the advantages of membership
June 18, 2025
As experts dedicated to providing patients with compassionate, evidence-based care every day, we are disappointed in the United States vs. Skrmetti decision, which increases the likelihood that other states will limit or eliminate families’ and patients’ ability to access medical care.
June 10, 2025
The American Medical Association (AMA) House of Delegates today passed the Endocrine Society’s resolution to improve access to anti-obesity medications.
June 05, 2025
The Endocrine Society today endorsed the introduction of the bipartisan Treat and Reduce Obesity Act (TROA) in the Senate.
June 17, 2025
The authors report on a 52-year-old man who presented with cerebrospinal fluid rhinorrhea and was found to have an invasive, 4.2-cm pituitary mass with modestly elevated prolactin (130.9 ng/mL [130.9 µg/L], reference range [RR] 2–18 ng/mL [2–18 µg/L]).
June 17, 2025
We evaluate whether time-restricted eating can improve pancreatic β-cell function and metabolic status in overweight individuals with early type 2 diabetes mellitus.
June 17, 2025
We investigate glucagonn receptor (GCGR) localization in the human brain and investigate the potential impact of lowered GCGR signaling on cognitive functions and, then validate our findings of GCGR expression in the frontal cortex using antibody-independent analyses.
